The Effect of Antiseizure Medication Administration on Mortality and Early Posttraumatic Seizures in Critically Ill Older Adults with Traumatic Brain Injury
Authors:
- 1 June 2022
- journal article
- research article
- Published by Springer Nature in Neurocritical Care
- Vol. 37 (2) , 538-546
Abstract
Background Traumatic brain injury (TBI) is a major cause of morbidity and mortality in the United States. Older adults represent an understudied and growing TBI population. Current Brain Trauma Foundation guidelines support prophylactic antiseizure medication (ASM) administration to reduce the risk of early posttraumatic seizures (within 7 days of injury) in patients with severe TBI. Whether ASM decreases mortality or early seizure risk in this population remains unclear. This study addresses the knowledge gap regarding the impact of ASM administration on the risk of seizure or mortality after TBI in patients more than 65 years of age. Methods This retrospective cohort study used a publicly available data set from the Medical Information Mart for Intensive Care-III from the Massachusetts Institute of Technology. Our cohort included patients 65 years or older with a primary exposure of early ASM administration with TBI resulting in an intensive care unit (ICU) admission in a level I trauma center from 2001 to 2012. A double-robust inverse propensity scale weighted model on the basis of proportional hazard and logistic regression models was created to assess the association between ASM administration and risk of death within 7 days of admission to the ICU. Secondary outcomes included 30-day mortality and 1-year mortality, early posttraumatic seizures, ICU length of stay, and hospital length of stay. Results Of 1145 patients 65 years or older with TBI admitted to an ICU, 783 (68.4%) received ASM within the first 24 h. Patients meeting inclusion criteria were predominantly white (83.8%) and were male (52.3%), with a median (interquartile range) age of 81 (74–86) years. TBI severity, classified by Glasgow Coma Score, was predominantly mild (71.2%), followed by moderate (16.8%) and severe (11.3%). Patients who received ASM were less likely to have died at 7 days (adjusted death hazard ratio [HR] = 0.48 [95% confidence interval {CI} 0.28–0.88], P = 0.005), at 30 days (adjusted HR 0.67 [95% CI 0.45–0.99], P = 0.045), and at 1 year (adjusted HR 0.72 [95% CI 0.54–0.97], P = 0.029). Groups were not different in regard to seizure (adjusted seizure odds ratio 1.18 [95% CI 0.61–2.26]) compared with those who did not receive ASM. Conclusions Early ASM administration was associated with reduced mortality at 7 days, 30 days, and 1 year but did not decrease the risk of early seizures among older adults who presented with TBI at an ICU. This benefit was observed in mild, moderate, and severe TBI assessed by Glasgow Coma Score on presentation among patients 65 years old and older and suggests broader recommendations for the use of ASM in older adults who present with TBI of any severity at an ICU.Keywords
This publication has 24 references indexed in Scilit:
- Traumatic brain injury in the United States: national estimates of prevalence and incidence, 2002–2006Injury Prevention, 2010
- A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative DataMedical Care, 2009
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007
- Post-traumatic epilepsy: An overviewClinical Neurology and Neurosurgery, 2006
- Continuous EEG monitoring in patients with traumatic brain injury reveals a high incidence of epileptiform activityActa Neurologica Scandinavica, 2006
- A randomized, double-blinded, placebo-controlled trial of phenytoin for the prevention of early posttraumatic seizures in children with moderate to severe blunt head injuryAnnals of Emergency Medicine, 2004
- Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoringJournal of Neurosurgery, 1999
- Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxisJournal of Neurosurgery, 1999
- A Randomized, Double-Blind Study of Phenytoin for the Prevention of Post-Traumatic SeizuresNew England Journal of Medicine, 1990
- Failure of prophylactically administered phenytoin to prevent late posttraumatic seizuresJournal of Neurosurgery, 1983